KUALA LUMPUR, May 21 — The Malaysia Healthcare Travel Council (MHTC), which is also known as Malaysia Healthcare signed two memorandums of understanding (MoU) on Thursday with China’s International Medical Exchange and Cooperation Committee (IMECC) and Hangzhou Rende Maternity Hospital respectively with the aim to collaboratively improve patient experience for healthcare travellers from China.
A statement from Malaysia Healthcare today said the partnerships will encourage knowledge exchange between IMECC and Hangzhou Rende Maternity Hospital with MHTC through a series of virtually conducted Continuous Medical Education (CME) sessions.
“Malaysian and Chinese healthcare experts will explore and discuss industry best practices and healthcare matters. Additionally, the partnership with each respective entity will also open doors for patients from China to seek safe and trusted treatment options with MHTC through consultations with their doctors at home,” said the statement.
MHTC chief executive officer Mohd Daud Mohd Arif said through partnerships with IMECC and Hangzhou Rende Maternity Hospital, healthcare travellers from China will benefit from a more holistic patient journey experience that offers continuity of care with excellent pre and post-care services.
“I look forward to the knowledge exchange sessions as this will strengthen our reputation for delivering world-class quality healthcare services which exemplifies patient trust and caters to the ever-changing healthcare traveler needs,” he said.
IMECC president, Ching Manho said IMECC is pleased to partner with MHTC, the government agency that promotes the country’s healthcare travel industry, known as Malaysia Healthcare, around the globe.
“With the acknowledgment of Malaysia’s renowned reputation in providing fertility, cardiology, and oncology treatments, we hope to establish a long-term partnership where both countries’ medical experts can join forces and work towards medical and service excellence,” he said.
Dean of Hangzhou Rende Maternity Hospital Ren Ding Xiang said the institution will be working closely with the Hangzhou Malaysia International Referral Centre to ensure a seamless patient experience for those seeking additional treatment in Malaysia.
According to the statement, Malaysia is increasingly the preferred healthcare destination for healthcare travellers from China, particularly since Malaysia has been positioned regionally as the fertility hub of Asia and has experienced a 300 per cent increase in demand for fertility treatments between 2011 to 2016.
By the same token, Malaysia has also been positioned as the cardiology hub of Asia, being home to highly reputable cardio health institutions which have achieved many breakthroughs in the field of cardiology. Moving forward, Malaysia will also be showcased as the cancer centre of excellence, the statement said.
